sFTX-3.3
Modify Date: 2025-08-25 18:23:39
sFTX-3.3 structure
|
Common Name | sFTX-3.3 | ||
|---|---|---|---|---|
| CAS Number | 141997-14-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of sFTX-3.3sFTX-3.3 is a Ca2+ channel antagonist with IC50s of approximately 0.24 mM and 0.70 mM against P-type and N-type channels[1][2]. |
| Name | SFTX-3.3 |
|---|
| Description | sFTX-3.3 is a Ca2+ channel antagonist with IC50s of approximately 0.24 mM and 0.70 mM against P-type and N-type channels[1][2]. |
|---|---|
| Related Catalog | |
| Target |
P-type calcium channel:0.24 mM (IC50) N-Type Ca2+ Channel:0.70 mM (IC50) |
| In Vitro | sFTX-3.3 (100 μM) reduces the duration of the slow component of presynaptic calcium currents by about 50% of the control and also reduces presynaptic sodium current by approximately 20% of the control. sFTX-3.3 (100 μM) reduces whole-cell sodium current recorded from SK.N.SH cells by approximately 15%[3]. |
| References |
| No Any Chemical & Physical Properties |